Freestone Grove Partners LP Purchases Shares of 206,590 Ralliant Corporation $RAL

Freestone Grove Partners LP purchased a new position in Ralliant Corporation (NYSE:RAL) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 206,590 shares of the company’s stock, valued at approximately $15,211,000. Freestone Grove Partners LP owned approximately 0.19% of Ralliant as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Dunhill Financial LLC bought a new stake in shares of Ralliant in the second quarter worth about $25,000. Global Retirement Partners LLC purchased a new stake in shares of Ralliant in the second quarter worth about $35,000. Group One Trading LLC bought a new position in Ralliant during the second quarter valued at approximately $36,000. Danske Bank A S bought a new position in Ralliant during the fourth quarter valued at approximately $25,000. Finally, Persistent Asset Partners Ltd purchased a new position in Ralliant during the 2nd quarter valued at approximately $37,000.

Insider Transactions at Ralliant

In other Ralliant news, CEO Tamara S. Newcombe sold 12,936 shares of the firm’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $71.79, for a total value of $928,675.44. Following the completion of the sale, the chief executive officer owned 251,967 shares of the company’s stock, valued at $18,088,710.93. This trade represents a 4.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $72.00, for a total transaction of $436,464.00. Following the completion of the sale, the senior vice president directly owned 31,668 shares of the company’s stock, valued at approximately $2,280,096. The trade was a 16.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.42% of the company’s stock.

Ralliant Price Performance

Shares of Ralliant stock opened at $63.44 on Friday. The stock has a market cap of $7.02 billion, a price-to-earnings ratio of -5.85, a price-to-earnings-growth ratio of 2.37 and a beta of 1.60. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. The stock has a 50 day moving average price of $68.53 and a 200-day moving average price of $56.39. Ralliant Corporation has a one year low of $37.27 and a one year high of $75.41.

Ralliant (NYSE:RAL) last announced its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.05. The business had revenue of $567.80 million for the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Equities analysts expect that Ralliant Corporation will post 2.87 EPS for the current year.

Ralliant Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Ralliant’s dividend payout ratio is -1.84%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on RAL. BMO Capital Markets started coverage on Ralliant in a report on Monday, July 20th. They set a “market perform” rating and a $78.00 price objective on the stock. Morgan Stanley raised their target price on shares of Ralliant from $68.00 to $85.00 and gave the company an “overweight” rating in a report on Tuesday, June 23rd. Citigroup boosted their price target on shares of Ralliant from $81.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Royal Bank Of Canada upped their price target on shares of Ralliant from $71.00 to $73.00 and gave the company a “sector perform” rating in a research note on Friday, July 31st. Finally, Oppenheimer increased their price objective on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Ralliant has a consensus rating of “Moderate Buy” and a consensus target price of $75.70.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.